News
Dupilumab-induced head and neck erythema described in atopic dermatitis patients
MADRID – “This is a common side effect that’s underreported in daily practice at this moment, and it’s not reported in clinical trials at all.”
News
New ustekinumab response predictor in Crohn’s called ‘brilliant’
SAN ANTONIO – The new clinical decision support tool can be used to sway payers to authorize earlier use of ustekinumab.
News
New ustekinumab response predictor in Crohn’s called ‘brilliant’
SAN ANTONIO – The new clinical decision support tool can be used to sway payers to authorize earlier use of ustekinumab.
News
Adult atopic dermatitis brings increased osteoporosis risk
MADRID – “The absolute risk is low, but it’s real.”
News
Which children are at greatest risk for atopic dermatitis?
MADRID – Pediatric atopic dermatitis risk varies according to type of parental history of atopic disease.
News
Human milk oligosaccharides quell IBS symptoms
SAN ANTONIO – Restoring the altered gut microbiota in patients with IBS pays off in reduced abnormal stools, pain, and bloating.
News
Biofeedback corrects dyssynergic constipation in elderly
SAN ANTONIO – “We propose that biofeedback be given strong consideration as first-line therapy for this population, in whom overall we’re trying...
News
CTS5 score partially validated for predicting late distant breast cancer recurrences
SAN ANTONIO – The CTS5 prognostic score is strongly predictive of risk of late distant recurrence of breast cancer in patients over age 50 at...
News
Promising new neoadjuvant strategy in luminal B breast cancer
SAN ANTONIO – Combining a CDK4/6 inhibitor with an aromatase inhibitor successfully downstages disease before surgery.
News
Tucatinib called game-changer in HER2-positive metastatic breast cancer
SAN ANTONIO – In the HER2CLIMB trial of women with heavily pretreated HER2-positive metastatic breast cancer, the 2-year estimated overall...
News
Some with mild Crohn’s disease need no treatment
SAN ANTONIO – Know the risk factors for progression of mild Crohn’s disease.
News
New evidence further supports starting CRC screening at age 45
SAN ANTONIO – American Cancer Society recommendation to lower starting age for colorectal cancer screening receives new support from a U.S....
News
Oral BTK inhibitor shows continued promise for pemphigus
MADRID – Definitive evidence of the drug’s efficacy and safety must await the results of the pivotal phase 3 PEGASUS trial.
News
A triple-antibiotic cure for Crohn’s disease?
SAN ANTONIO – “I see this as we’re standing at the same place now as we were standing with Helicobacter pylori 30 years ago.” – Dr. David...
News
Effective NASH medications are coming ‘sooner than you think’
SAN ANTONIO – New NASH drugs will transform clinical practice.